Belvedere Trading »

Iovance Biotherapeutics shares owned by Belvedere Trading

Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Belvedere Trading from 13F filings

Historical chart of Belvedere Trading investment in Iovance Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Iovance Biotherapeutics held by Belvedere Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Iovance Biotherapeutics by Belvedere Trading

Quarter filed Position value Share count Share price at filing
2023-09-30 $61k 13k 4.55
2022-03-31 $275k 17k 16.51

More positions owned by Belvedere Trading

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors (TSLA)
Ishares Tr Russell 2000 Etf (IWM)
Meta Platforms Cl A (META)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Amazon Call Option (AMZN)
Spdr Gold Tr Gold Shs (GLD)
Microstrategy Cl A New (MSTR)
Ishares Silver Tr Ishares (SLV)
Kraneshares Tr Global Carb Stra (KRBN)
Global X Fds Global X Uranium Call Option (URA)
Alphabet Cap Stk Cl A (GOOGL)
Carvana Cl A Call Option (CVNA)

View all positions for Belvedere Trading

Top funds holding Iovance Biotherapeutics

Vanguard Group
MHR Fund Management
Perceptive Advisors
venBio Select Advisor
Artisan Partners Limited Partnership
OrbiMed Advisors
Balyasny Asset Management
Goldman Sachs Group
Dimensional Fund Advisors
T. Rowe Price Associates
Jpmorgan Chase & Co
Credit Suisse
Principal Financial Group
Long Focus Capital Management
Palo Alto Investors

View all funds holding Iovance Biotherapeutics